CRITICAL CARE OF CARDIOVASCULAR SYSTEM II

Further, as the cohort of critically ill patients slowly shifts away from postoperative care to include more patients with end-stage heart failure, multiorgan disease, etc, the score of mortality risk, high morbidity and cost of care in critically ill children is still a challenge for Pediatric Intensivists. The goal of treatment of HF in children is to maintain stability, prevent progression, and provide a reasonable milieu to allow somatic growth and optimal development. At the same time, there are significant challenges in performing well-designed drug trials in children with HF because of heterogeneity of diagnoses identifying a clinically relevant outcome with a high event rate, and a difficulty in achieving sufficient enrolment. This Webinar will provide the outlook for evolving therapies and focus on practical issues required for management of pediatric HF.

DATE: FRIDAY, 23 APRIL 2021
TIME: 09.00 – 11.15 WIB